ICH - M7 on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals

[Naiffer_Host]

ICH guideline M7(R1) on assessment and control of DNA
reactive (mutagenic) impurities in pharmaceuticals to
limit potential carcinogenic risk

https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-m7r1-assessment-control-dna-reactive-mutagenic-impurities-pharmaceuticals-limit_en.pdf